Alpha-smooth muscle actin expression enhances cell traction force.
Using an established corneal stromal cell differentiation model, we manipulated alpha-smooth muscle actin (alpha-SMA) protein expression levels in fibroblasts by treating them with TGF-beta1, bFGF, TGF-beta type I receptor inhibitor (SB-431542), and siRNA against alpha-SMA. The corresponding cell traction forces (CTFs) were determined by cell traction force microscopy. With all these treatments, we found that alpha-SMA is not required for CTF induction, but its expression upregulates CTF. This upregulation involves the modification of stress fibers but does not appear to relate to non-muscle myosin II expression or beta-actin expression. Moreover, there exists a linear relationship between alpha-SMA protein expression level and CTF magnitude. Finally, CTFs were found to vary among a population of myofibroblasts, suggesting that alpha-SMA protein expression levels of individual cells also vary.
Chen
Jianxin
J
Department of Orthopaedic Surgery, MechanoBiology Laboratory, University of Pittsburgh, Pennsylvania 15213, USA.
Li
Hongxia
H
SundarRaj
Nirmala
N
Wang
James H-C
JH
D000199:Actins / Q000096:biosynthesis* / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D000818:Animals; D001549:Benzamides / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects / Q000502:physiology; D003319:Corneal Stroma / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D004149:Dioxoles / Q000494:pharmacology; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology; D040542:Mechanotransduction, Cellular; D009130:Muscle, Smooth / Q000378:metabolism* / Q000502:physiology; D024462:Myosin Type II / Q000096:biosynthesis / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics; D011817:Rabbits; D013314:Stress, Mechanical; D017154:Stromal Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D053773:Transforming Growth Factor beta1 / Q000494:pharmacology
C459179:4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide; D000199:Actins; D001549:Benzamides; D004149:Dioxoles; D034741:RNA, Small Interfering; D053773:Transforming Growth Factor beta1; D016222:Fibroblast Growth Factor 2; D024462:Myosin Type II